Grupo Cibest Reports 39% Net Income Drop Amidst $1.3B Goodwill Impairment from Banistmo Sale
summarizeSummary
Grupo Cibest S.A. reported a 39% decline in 2025 net income due to a $1.3 billion goodwill impairment from the Banistmo sale, alongside significant political and regulatory risks, despite improved asset quality and share repurchases.
check_boxKey Events
-
Significant Net Income Decline
Net income attributable to equity holders decreased by 39.04% in 2025 to COP 3,821 billion, down from COP 6,268 billion in 2024.
-
Major Goodwill Impairment
A goodwill impairment charge of COP 5,022,822 million (approximately $1.33 billion USD) was recorded in 2025, stemming from the reclassification of Banistmo as a discontinued operation.
-
Banistmo Divestiture Agreement
Grupo Cibest reached an agreement on December 18, 2025, to sell 100% of Banistmo S.A. for USD 1.418 billion, with assets and liabilities reclassified as held for sale.
-
Credit Rating Downgrades
Colombia's sovereign debt rating was downgraded by Fitch and S&P in 2025, leading to revised credit ratings for Bancolombia and Grupo Cibest, increasing borrowing costs.
auto_awesomeAnalysis
Grupo Cibest S.A. reported a significant 39.04% decrease in net income attributable to equity holders for 2025, primarily driven by a substantial COP 5,022,822 million (approximately $1.33 billion USD) goodwill impairment related to the agreement to sell its Panamanian subsidiary, Banistmo. This divestiture, valued at USD 1.418 billion, marks a major strategic shift. The company also faces heightened macroeconomic and political risks, including the downgrade of Colombia's sovereign credit rating and the inclusion of the Colombian President on the U.S. SDN list, which could impact investor sentiment and operational stability. Post-period, the Colombian Central Bank raised interest rates twice in early 2026, signaling persistent inflationary pressures and a tighter monetary environment. While the company executed COP 431.4 billion in share repurchases and saw improved asset quality in its core banking operations, these positives are overshadowed by the large impairment and the complex risk landscape.
At the time of this filing, CIB was trading at $75.36 on NYSE in the Unknown sector, with a market capitalization of approximately $20.1B. The 52-week trading range was $35.44 to $86.31. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.